| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
ContraFect Corporation (NASDAQ: CFRX)
CFRX Technical Analysis
5
| As on 7th Feb 2024 CFRX STOCK Price closed @ 0.03 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.01 & Strong Sell for SHORT-TERM with Stoploss of 0.20 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CFRXSTOCK Price
| Open | 0.03 | Change | Price | % |
| High | 0.03 | 1 Day | 0.00 | 0.00 |
| Low | 0.03 | 1 Week | 0.00 | 0.00 |
| Close | 0.03 | 1 Month | 0.00 | 0.00 |
| Volume | 2204 | 1 Year | -0.24 | -88.89 |
| 52 Week High 5.12 | 52 Week Low 0.03 | ||||
NASDAQ USA Most Active Stocks
| AMRS | 0.14 | 100.00% |
| DGLY | 0.06 | 20.00% |
| GNLN | 0.01 | 0.00% |
| NVDA | 117.37 | 0.26% |
| LMDX | 0.02 | 0.00% |
| PLUG | 0.85 | 8.97% |
| AKTS | 0.04 | 0.00% |
| TSLA | 284.82 | 3.11% |
| ZKIN | 2.52 | 123.01% |
| VEEE | 7.45 | 192.16% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| CFRX Daily Charts |
CFRX Intraday Charts |
Whats New @ Bazaartrend |
CFRX Free Analysis |
|
|
CFRX Important Levels Intraday
| RESISTANCE | 0.03 |
| RESISTANCE | 0.03 |
| RESISTANCE | 0.03 |
| RESISTANCE | 0.03 |
| RESISTANCE | 0.03 |
| RESISTANCE | 0.03 |
| RESISTANCE | 0.03 |
| RESISTANCE | 0.03 |
CFRX Forecast May 2025
| 4th UP Forecast | 0.34 |
| 3rd UP Forecast | 0.24 |
| 2nd UP Forecast | 0.18 |
| 1st UP Forecast | 0.12 |
| 1st DOWN Forecast | -0.06 |
| 2nd DOWN Forecast | -0.12 |
| 3rd DOWN Forecast | -0.18 |
| 4th DOWN Forecast | -0.28 |
CFRX Weekly Forecast
| 4th UP Forecast | 0.18 |
| 3rd UP Forecast | 0.13 |
| 2nd UP Forecast | 0.10 |
| 1st UP Forecast | 0.07 |
| 1st DOWN Forecast | -0.01 |
| 2nd DOWN Forecast | -0.04 |
| 3rd DOWN Forecast | -0.07 |
| 4th DOWN Forecast | -0.12 |
CFRX Forecast2025
| 4th UP Forecast | 13.19 |
| 3rd UP Forecast | 8.97 |
| 2nd UP Forecast | 6.36 |
| 1st UP Forecast | 3.75 |
| 1st DOWN Forecast | -3.69 |
| 2nd DOWN Forecast | -6.3 |
| 3rd DOWN Forecast | -8.91 |
| 4th DOWN Forecast | -13.13 |
ContraFect Corporation ( NASDAQ USA Symbol : CFRX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CFRX Business Profile
ContraFect Corporation, a clinical-stage biotechnology company, focuses on the discovery and development of therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious diseases in the United States. Its lead product candidates consist of CF-301, an investigational novel lysin, which is in Phase III clinical trials for the treatment of staphylococcus aureus bacteremia, including endocarditis caused by methicillin-resistant or methicillin-susceptible. The company also develops CF-296, an engineered lysin, used for treatment of the invasive infections caused by staph aureus including biofilm-related infections in prosthetic joints and indwelling devices and osteomyelitis; and CF-370, an investigational anti-bacterial therapeutic candidate, which in preclinical trials for the treatment of pseudomonas aeruginosa infections, including ventilator associated pneumonia, blood stream infections, complicated urinary tract infections, and surgery carry infections. The company has a collaboration research agreement with The Rockefeller University to identification of novel lysin therapeutic candidates targeting gram-negative pathogens. It also initiated an expanded access program to provide exebacase for the treatment of persistent bacteremia caused by methicillin-resistant Staphylococcus aureus in COVID-19 patients. The company was incorporated in 2008 and is headquartered in Yonkers, New York. Address: 28 Wells Avenue, Yonkers, NY, United States, 10701
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service